Skip to content
10-Q

Quarterly Report

Medicale Corp. MCLE

0001683168-24-001005

← back to feed
Filed
Feb 15, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Feb 14, 2024 5.92M sh
Current Liabilities Q1 2024 · Dec 31, 2023 $12K
Current Liabilities Q1 2024 · Sep 30, 2023 $40.88K
Total Liabilities Q1 2024 · Dec 31, 2023 $60.19K
Total Liabilities Q1 2024 · Sep 30, 2023 $40.88K
Current Assets Q1 2024 · Dec 31, 2023 $159
Current Assets Q1 2024 · Sep 30, 2023 $159
Total Assets Q1 2024 · Dec 31, 2023 $159
Total Assets Q1 2024 · Sep 30, 2023 $159
Shares Diluted Q1 2024 · Dec 31, 2022 5.92M sh
Operating Cash Flow restated Q1 2024 · Dec 31, 2022 $159
Stockholders Equity Q1 2024 · Dec 31, 2022 −$11.84K
Stockholders Equity Q1 2024 · Sep 30, 2022 −$54.77K
Sga Expense Q1 2024 · Dec 31, 2022 $8.71K
Net Income Q1 2024 · Dec 31, 2022 −$8.26K
Operating Income Q1 2024 · Dec 31, 2022 −$8.71K